Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock factor 1 (HSF1) is the master transcription factor responsible for the biological process known as the heat shock response or "heat induction" of molecular chaperones (PMID: 2150530). Under basal conditions, HSF1 is primarily sequestered in an inactive monomeric state by chaperones such as HSP90 and HSP70. Upon exposure to thermal or proteotoxic stress, HSF1 is released, undergoes homotrimerization, and translocates to the nucleus where it binds to heat shock elements (HSEs) in the promoters of target genes. This activation leads to the rapid transcription of heat shock proteins (HSPs), which act as chaperones to maintain protein homeostasis and prevent apoptosis under stressful conditions (PMID: 22441905). In the context of human disease, HSF1 is a major therapeutic target in oncology because cancer cells frequently overexpress HSF1 to survive the metabolic and proteotoxic stressors of the tumor microenvironment (PMC2670238). Conversely, HSF1 activation is being explored as a strategy for treating neurodegenerative diseases, where the heat induction of chaperones can facilitate the clearance of toxic protein aggregates. Small molecule inhibitors, such as triptolide and quercetin, have been shown to interfere with HSF1-mediated transcriptional activity, effectively blocking the heat induction of cytoprotective proteins like HSP70 (PMC2670238). Recent drug development efforts focus on direct HSF1 inhibitors to overcome the specific proteotoxic dependencies of aggressive tumors.
Inhibition of HSF1 trimerization, DNA binding, or phosphorylation to prevent the induction of heat shock proteins and sensitize cells to proteotoxic stress.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock factor 1 (HSF1) (HSF1).